Dare Bioscience rises on promising data from hormone therapy

Dare Bioscience

17/10/2022 17:10

** Dare Bioscience Inc's shares  DARE.O  rise 4.5% to $0.93 
    ** Drugmaker says its experimental hormone therapy to treat
women with conditions associated with menopause - including hot
flashes, night sweats and dryness - demonstrated statistically
significant improvement in early-to-mid stage trial  urn:newsml:reuters.com:*:nGNX1lLvqV
    ** The study was well-tolerated, with no adverse events -
DARE
    ** Including session gains, stock lost ~53% YTD 
 (Reporting by Khushi Mandowara)
 ((Khushi.Mandowara@thomsonreuters.com;))